Franklin Lakes, NJ, (Dec. 8, 2025) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, is showcasing the latest advances in connected medication management technology this week at the American Society of Health-System Pharmacists (ASHP) 2025 Midyear Clinical Meeting and Exhibition in Las Vegas, Nev.
Conference-goers can visit Booth #1017 to get a comprehensive demonstration of BD’s newest connected care solutions that empower clinicians to deliver care with enhanced safety and efficiency, including:
- Flexible, secure storage to get the right medication to the right patient, faster: The next-generation BD Pyxis™ Pro Dispensing Solution delivers smarter medication storage that supports faster access at the point of care. The first-of-its-kind flexible, stackable device configuration offers more secure medication storage capacity to improve medication availability from refrigerated to ambient storage.
- AI-powered analytics to drive smarter, faster decisions: The BD Incada™ Connected Care Platform is a scalable, AI-enabled, cloud-based platform unifies BD device data into one intelligent ecosystem. ASHP Midyear 2025 attendees can see the BD Incada™ Platform in action and get a hands-on demonstration of how it is leveraging the latest in AI technologies, such as natural language search in analytics with the BD Pyxis™ Pro Solution, to create enterprise-wide visibility and connectivity that transforms data into actionable insight.
- High-speed dispensing robot for boxed medications: Widely used across Europe, BD Rowa™ Vmax will introduce high-speed unit-of-use automation to the U.S. market, transforming how boxed medications are picked and replenished in Central Fill environments. With the add-on EasyLoad feature, BD Rowa™ Vmax enables fully automated replenishment, allowing pharmacy teams to load boxes at the end of the day while the robot works overnight to restock the system. ASHP Midyear 2025 marks the official unveiling of this renowned technology for customers in the United States as part of the BD Parata Central Fill offering.
- Inventory management with RFID: The 2025 ASHP Midyear Clinical Meeting and Exhibition also marks the introduction of a new strategic partnership between BD, Marble AI, and Terso Solutions to enhance central pharmacy inventory management of high-cost and critical medications using the latest RFID technologies. This innovative technology leverages the Terso Solutions RFID-enabled hardware and flexible, cloud-native software from Marble AI to automate the receiving, storing, and tracking of specialty pharmaceuticals. The solution will integrate into the BD Connected Care ecosystem to help provide customers with visibility and control to help reduce errors and improve operational efficiency.
“Medication management is no longer just about storage and dispensing, it’s about creating a connected ecosystem that turns data into actionable insights,” said Connor Bates, worldwide president for Medication Management Solutions at BD. “By integrating AI, automation, robotics and data-driven insights into our solutions, we’re advancing our vision for a future where clinicians have the tools and intelligence they need to make faster, smarter decisions.”
For more information or to schedule a demonstration, visit BD.com.
About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/, X (formerly Twitter) @BDandCo or Instagram @becton_dickinson.
Contacts:
Media:
Hallie Nicholson
Associate Director, Communications
760.201.6604
hallie.nicholson@bd.com
Investors:
Adam Reiffe
VP, Investor Relations
201.847.6927
adam.reiffe@bd.com